Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U.
#Atrial flutter causes during pregnancy trial#
A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. The cardiac arrhythmia suppression trial.
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. 1995 12(1):55–72.Įcht DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Propafenone in the treatment of cardiac arrhythmias. Flecainide in the treatment of fetal tachycardias. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, et al. Use of flecainide for refractory atrial tachycardia of pregnancy. Initiation of uterine contractions by disopyramide during pregnancy. Treatment of arrhythmias during pregnancy. Procainamide administration during pregnancy. Antiarrhythmic drug therapy in pregnancy and lactation. The use of quinidine sulfate throughout pregnancy. Treatment of cardiac arrhythmias during pregnancy. Treatment of cardiac arrhythmias during pregnancy: safety considerations. The 2015 US food and drug administration pregnancy and lactation labeling rule. SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. 2007 27(6):1705–22.īest PJ, Skelding KA, Mehran R, Chieffo A, Kunadian V, Madan M, et al. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Pregnancy outcomes in women with heart disease: the CARPREG II study. Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Martin JAHB, Osterman MJK, Driscoll AK, Drake P. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Li JM, Nguyen C, Joglar JA, Hamdan MH, Page RL. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U. Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking. 1986 154(1):80–4.Īnneken L, Baumann S, Vigneault P, Biliczki P, Friedrich C, Xiao L, et al. Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. 1981 20(1):52–8.īarron WM, Mujais SK, Zinaman M, Bravo EL, Lindheimer MD. Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids. Hormone sensitive idiopathic ventricular tachycardia associated with pregnancy: successful induction with progesterone and radiofrequency ablation. Makhija A, Sharada K, Hygriv Rao B, Thachil A, Narsimhan C. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, et al. The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Contemporary management of arrhythmias during pregnancy. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia.
Lee SH, Chen SA, Wu TJ, Chiang CE, Cheng CC, Tai CT, et al. Vaidya VR, Arora S, Patel N, Badheka AO, Patel N, Agnihotri K, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al.
0 kommentar(er)
